PURPOSE: The purpose of the current study was to investigate the effects of two important excipients, zinc and m-cresol, on the self-association properties of a series of monomeric insulin analogs. In this way, the effects on formulation behavior of individual amino acid substitutions in the C-terminal region of the insulin B-chain could be compared. METHODS: The self-association of ten insulin analogs was monitored by equilibrium and velocity analytical ultracentrifugation under three different conditions: (i) in neutral buffer alone; (ii) in neutral buffer containing zinc ion; and (iii) in neutral buffer containing both zinc ion and phenolic preservative (a typical condition for insulin formulations). The self-association properties of these analogs were compared to those of human insulin and the rapid-acting insulin analog Lys(B28)Pro(B29)-human insulin. RESULTS: The analogs in the current study exhibited a wide range of association properties when examined in neutral buffer alone or in neutral buffer containing zinc ion. However, all of these analogs had association properties similar to human insulin in the presence of both zinc and m-cresol. Under these formulation conditions each analog had an apparent sedimentation coefficient of s* = 2.9-3.1 S, which corresponds to the insulin hexamer. CONCLUSIONS: Analogs with changes in the B27-B29 region of human insulin form soluble hexamers in the presence of both zinc and m-cresol, and m-cresol binding overrides the otherwise destabilizing effects of these mutations on self assembly.
PURPOSE: The purpose of the current study was to investigate the effects of two important excipients, zinc and m-cresol, on the self-association properties of a series of monomeric insulin analogs. In this way, the effects on formulation behavior of individual amino acid substitutions in the C-terminal region of the insulin B-chain could be compared. METHODS: The self-association of ten insulin analogs was monitored by equilibrium and velocity analytical ultracentrifugation under three different conditions: (i) in neutral buffer alone; (ii) in neutral buffer containing zinc ion; and (iii) in neutral buffer containing both zinc ion and phenolic preservative (a typical condition for insulin formulations). The self-association properties of these analogs were compared to those of humaninsulin and the rapid-acting insulin analog Lys(B28)Pro(B29)-humaninsulin. RESULTS: The analogs in the current study exhibited a wide range of association properties when examined in neutral buffer alone or in neutral buffer containing zinc ion. However, all of these analogs had association properties similar to humaninsulin in the presence of both zinc and m-cresol. Under these formulation conditions each analog had an apparent sedimentation coefficient of s* = 2.9-3.1 S, which corresponds to the insulin hexamer. CONCLUSIONS: Analogs with changes in the B27-B29 region of humaninsulin form soluble hexamers in the presence of both zinc and m-cresol, and m-cresol binding overrides the otherwise destabilizing effects of these mutations on self assembly.
Authors: U Derewenda; Z Derewenda; E J Dodson; G G Dodson; C D Reynolds; G D Smith; C Sparks; D Swenson Journal: Nature Date: 1989-04-13 Impact factor: 49.962
Authors: D L Bakaysa; J Radziuk; H A Havel; M L Brader; S Li; S W Dodd; J M Beals; A H Pekar; D N Brems Journal: Protein Sci Date: 1996-12 Impact factor: 6.725
Authors: E N Baker; T L Blundell; J F Cutfield; S M Cutfield; E J Dodson; G G Dodson; D M Hodgkin; R E Hubbard; N W Isaacs; C D Reynolds Journal: Philos Trans R Soc Lond B Biol Sci Date: 1988-07-06 Impact factor: 6.237
Authors: L J Slieker; G S Brooke; R D DiMarchi; D B Flora; L K Green; J A Hoffmann; H B Long; L Fan; J E Shields; K L Sundell; P L Surface; R E Chance Journal: Diabetologia Date: 1997-07 Impact factor: 10.122
Authors: Anjul Khadria; Chad D Paavola; Konstantin Maslov; Francisco A Valenzuela; Andrea E Sperry; Amy L Cox; Rui Cao; Junhui Shi; Patricia L Brown-Augsburger; Emmanuel Lozano; Ross L Blankenship; Ranajoy Majumdar; Scott A Bradley; John M Beals; Sunday S Oladipupo; Lihong V Wang Journal: Mol Metab Date: 2022-06-04 Impact factor: 8.568
Authors: Yatin R Gokarn; R Matthew Fesinmeyer; Atul Saluja; Shawn Cao; Jane Dankberg; Andrew Goetze; Richard L Remmele; Linda O Narhi; David N Brems Journal: Protein Sci Date: 2009-01 Impact factor: 6.725
Authors: Ahter D Sanlioglu; Hasan Ali Altunbas; Mustafa Kemal Balci; Thomas S Griffith; Salih Sanlioglu Journal: Islets Date: 2013-03-01 Impact factor: 2.694
Authors: Anna Lih; Emily Hibbert; Tang Wong; Christian M Girgis; Nidhi Garg; John N Carter Journal: Diabetes Metab Syndr Obes Date: 2010-11-26 Impact factor: 3.168
Authors: Tine N Vinther; Mathias Norrman; Holger M Strauss; Kasper Huus; Morten Schlein; Thomas Å Pedersen; Thomas Kjeldsen; Knud J Jensen; František Hubálek Journal: PLoS One Date: 2012-02-17 Impact factor: 3.240
Authors: Gary G Adams; Andrew Meal; Paul S Morgan; Qushmua E Alzahrani; Hanne Zobel; Ryan Lithgo; M Samil Kok; David T M Besong; Shahwar I Jiwani; Simon Ballance; Stephen E Harding; Naomi Chayen; Richard B Gillis Journal: PLoS One Date: 2018-03-29 Impact factor: 3.240